当前位置： SCI文献检索 > Molecular Genetics & Genomic Medicine期刊下所有文献 > Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype.

Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype.

Abstract：

BACKGROUND:Submicroscopic chromosomal imbalance is associated with an increased nuchal translucency (NT). Most previous research has recommended the use of chromosomal microarray analysis (CMA) for prenatal diagnosis if the NT ≥ 3.5 mm. However, there is no current global consensus on the cutoff value for CMA. In this study, we aimed to discuss the fetuses with smaller increased NT which was between cutoff value of NT for karyotype analysis (NT of 2.5 mm in China) and the recommended cutoff value for CMA (NT of 3.5 mm) whether should be excluded from CMA test. METHODS:Singleton pregnant women (N = 192) who had undergone invasive procedures owing to an increased NT (NT ≥ 2.5 mm) were enrolled. Fetal cells were collected and subjected to single nucleotide polymorphism array and karyotype analyses simultaneously. Cases were excluded if the karyotype analysis indicated aneuploidy and apparent structural aberrations. RESULTS:Fourteen cases of aneuploidy and four cases of structural abnormalities were excluded. Of the remaining 174 cases, 119 fetuses had NTs of 2.5-3.4 mm, and 55 fetuses with NT ≥ 3.5 mm. Eleven copy number variants (CNVs) were identified. In fetuses with smaller NTs, six (6/119, 5.9%) variations were detected, including two (2/119, 1.6%) clinically significant CNVs (pathogenic or likely pathogenic CNV), one likely benign CNV, two variants unknown significance, and one incidental CNV. Five (5/55, 9.1%) variations were found in fetuses with NT ≥ 3.5 mm. Among these CNVs, three (3/55, 5.5%) cases had clinically significant CNVs, and two had likely benign CNV. There were no statistically significant differences in the incidence of all CNVs and clinically significant CNVs in the two groups (p > 0.05). CONCLUSION:CMA improved the diagnostic yield of chromosomal aberrations for fetuses with NTs of 2.5-3.4 mm and apparently normal karyotype, regardless of whether other ultrasonic abnormalities were observed.

journal_name

Mol Genet Genomic Med

journal_title

Molecular genetics & genomic medicine

authors

Su L,Huang H,An G,Cai M,Wu X,Li Y,Xie X,Lin Y,Wang M,Xu L

doi

10.1002/mgg3.811

subject

Has Abstract

pub_date

2019-08-01 00:00:00

pages

e811

issue

issn

2324-9269

journal_volume

pub_type

杂志文章

在线工具

Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype.